NAVER D2SF Doubles Down on AI-Powered Diagnostics Startup Soundable Health
Event summary
- NAVER D2SF, NAVER’s corporate venture arm, made a follow-on investment in Soundable Health in a Pre-Series A round.
- Soundable Health’s flagship product, proudP, uses AI to analyze urine flow sounds for diagnostics, achieving 97% accuracy.
- proudP is an FDA Class II medical device with over 50,000 patients and 130 urology clinics currently using the solution.
- Soundable Health expects accelerated adoption in 2026 with potential insurance reimbursement, including Medicare.
The big picture
Soundable Health’s approach to diagnostics—leveraging AI and everyday devices for accessible, at-home testing—aligns with the broader trend of democratizing healthcare and shifting care delivery models. NAVER D2SF’s continued investment signals confidence in this approach and the company’s ability to execute, particularly as the global aging population drives demand for remote monitoring solutions. The company’s FDA Class II designation and focus on reimbursement are key de-risking factors for future growth.
What we're watching
- Reimbursement Impact
- Medicare and other insurance coverage will be a critical driver of Soundable Health’s growth trajectory, and the timing and scope of this coverage will significantly impact adoption rates.
- Platform Expansion
- The company's stated intention to expand its platform beyond urology into respiratory health and other areas will determine the breadth of its market opportunity and the efficiency of its AI model development.
- B2B Partnerships
- The success of Soundable Health’s B2B partnerships with pharmaceutical, medical device, and consumer electronics companies will be key to scaling its reach and integrating its technology into broader healthcare ecosystems.
Related topics